Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1367 |
|
| Actual shortage: | 56 (4%) | |
| Anticipated shortage: | 6 (0%) | |
| Avoided shortage: | 37 (3%) | |
| Resolved: | 1268 (93%) | |
Discontinuation Reports |
291 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 287 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
211 (13%) |
|
Overdue reports |
8 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-SUMATRIPTAN | 100MG | TABLET | Resolved | 2019-07-31 | 2020-06-10 | 90488 |
| PMS-SUMATRIPTAN | 100MG | TABLET | Resolved | 2019-07-31 | 2019-09-12 | 90491 |
| PMS-SUMATRIPTAN | 50MG | TABLET | Resolved | 2024-03-15 | 2024-07-18 | 222384 |
| PMS-SUMATRIPTAN | 25MG | TABLET | Resolved | 2025-04-01 | 2025-05-12 | 253882 |
| PMS-TADALAFIL | 10MG | TABLET | Resolved | 2017-06-07 | 2018-04-19 | 12231 |
| PMS-TADALAFIL | 20MG | TABLET | Resolved | 2017-09-19 | 2017-10-26 | 22817 |
| PMS-TADALAFIL | 20MG | TABLET | Resolved | 2017-12-08 | 2018-04-19 | 32148 |
| PMS-TADALAFIL | 2.5MG | TABLET | Resolved | 2018-02-06 | 2020-06-03 | 38863 |
| PMS-TADALAFIL | 20MG | TABLET | Avoided shortage | 2018-08-24 | 2018-09-19 | 59128 |
| PMS-TADALAFIL | 10MG | TABLET | Resolved | 2018-09-19 | 2020-06-03 | 61900 |
| PMS-TADALAFIL | 20MG | TABLET | Resolved | 2018-10-19 | 2020-06-03 | 64838 |
| PMS-TADALAFIL | 5MG | TABLET | Resolved | 2018-11-29 | 2020-06-03 | 67969 |
| PMS-TADALAFIL | 20MG | TABLET | Resolved | 2018-11-29 | 2020-06-03 | 67972 |
| PMS-TADALAFIL | 5MG | TABLET | Resolved | 2019-01-16 | 2020-06-03 | 72645 |
| PMS-TADALAFIL | 10MG | TABLET | Resolved | 2022-08-15 | 2022-12-01 | 166794 |
| PMS-TADALAFIL | 2.5MG | TABLET | Resolved | 2023-06-09 | 2023-08-07 | 194515 |
| PMS-TADALAFIL | 5MG | TABLET | Resolved | 2024-02-07 | 2024-04-25 | 218779 |
| PMS-TADALAFIL | 10MG | TABLET | Resolved | 2024-02-07 | 2024-04-12 | 218782 |
| PMS-TADALAFIL | 5MG | TABLET | Resolved | 2025-02-18 | 2025-04-11 | 250574 |
| PMS-TELMISARTAN | 40MG | TABLET | Resolved | 2024-09-12 | 2024-12-02 | 237394 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ZOLEDRONIC ACID | 4MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6094 |
| PMS-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117894 |
| PMS-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-07-25 | 2022-07-25 | 165469 |
| PMSC-METFORMIN | 500MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248798 |
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |